NCT03691818View on ClinicalTrials.gov

Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

October 21, 2019

Study Completion Date

October 21, 2019

Conditions
KNEE OSTEOARTHRITIS
Interventions
DRUG

X0002 Spray

According to the different dose groups assigned, each knee joint was sprayed with 1, 2 or 4 sprays.

DRUG

Ibuprofen Tablet

Ibuprofen Tab 400mg, tid.

DRUG

Ibuprofen Placebo Tab

Ibuprofen Placebo Tab 400mg, tid.

DRUG

X0002 Placebo Spray

According to the different dose groups assigned, each knee joint was sprayed with 1, 2 or 4 sprays.

Trial Locations (1)

100005

Chinese Academy of Medical Science & Peking Union Medical college Hospital, Beijing

All Listed Sponsors
lead

Tianjin XinChen-Techfields Pharma Co., LTD.

INDUSTRY

NCT03691818 - Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis | Biotech Hunter | Biotech Hunter